Forum for Collaborative HIV Research Announces New Deputy
WASHINGTON, D.C., January 7, 2010 - The Forum for
Collaborative HIV Research is pleased to announce that, effective today, Jur
Strobos MD JD joins the Forum as its Deputy Director.
Dr. Strobos brings to the Forum more than 30 years of
experience working in patient health care, clinical research, and international
drug regulation. His areas of expertise include drug law, clinical study
design and good manufacturing practices. His medical experience was shaped
during the early years of the HIV epidemic, when, as a surgical resident at Bellevue Hospital
in New York City,
he began seeing young men dying from an unusual and then-unexplained illness.
His pro bono public service includes six years as a clinical and pharmaceutical
development consultant for the AIDS Research Alliance.
"Dr. Strobos' diverse areas of expertise embody the Forum's
own approach to interdisciplinary collaboration," said Dr. Veronica Miller, the
Forum's Executive Director. "Jur brings intimate knowledge of the worlds
of patient care, drug development, government and public policy. His executive
management experience spans the public and private sectors."
The Forum for Collaborative HIV Research works to identify
and advance emerging issues in the prevention, care and treatment of people
affected by HIV/AIDS. As Deputy Director, Dr. Strobos will collaborate closely
with Dr. Miller to develop the Forum's long-term vision, hone its strategy and
strengthen relationships with regulatory agencies. In addition, he will
help to lead efforts that span the complex nexus of regulatory and development
issues related to new drug development and delivery for patients with
"The year 2010 offers new opportunities to advance the
testing and therapies that can turn around the HIV/AIDS epidemic," said Dr.
Judith Aberg, co-chair of the Forum Executive Committee and Director of
Virology at the New York University School of Medicine. "We welcome Dr. Strobos
to the Forum's leadership team in this time of change and promise."
Dr. Strobos served as Director of Policy Research in
the Office of the Commissioner of the Food and Drug Administration (FDA).
There, he worked closely with then-FDA Commissioner Kessler on a number of
issues, including standards for review of pharmaceutical products, the design
of clinical studies, and international harmonization of review standards.
His regulatory and clinical consulting work has been based
at the law firm of Olsson Frank Weeda Terman Bode Matz, PC, Washington, DC,
and has included the impact on regulatory policy in the review of applications
in AIDS drugs, orthopedics, oncology, nephrology, hematology, and cell
therapy. Strobos has also consulted on international regulatory issues
regarding Canadian and EMEA Drug Regulations.
While at Olsson, Dr. Strobos has also served, on an interim
basis, as Vice-President of Clinical Research and Regulatory Affairs for three
pharmaceutical companies, where he guided the nonclinical and clinical development
of drugs, medical devices, and biological products.
Dr. Strobos received degrees from Johns Hopkins University
(BA), the University of Chicago Pritzker School of Medicine (MD) and the
University of Pennsylvania Law School (JD).